MeSH D054908 - extensively drug-resistant tuberculosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Mylan | Pretomanid | Dovprela (previously Pretomanid FGK) | 2020-07-31 | |||
| Pretomanid | Pretomanid | 2019-08-14 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
100%16/16
Phase 3
11%2/18
Approved: 1Overall Success rate: 11%
All Clinical Trials
No data
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use